Your email has been successfully added to our mailing list.

×
0 0 0 0 0.0295566502463054 0.0295566502463054 0.0295566502463054 0.0295566502463054
Stock impact report

MEI Pharma +16.7% on updated early-stage trial data [Seeking Alpha]

MEI Pharma, Inc. (MEIP) 
Last mei pharma, inc. earnings: 2/6 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.meipharma.com
Company Research Source: Seeking Alpha
MEI Pharma +16.7% on updated early-stage trial data MEI Pharma (NASDAQ: MEIP risen another 16.7% updated clinical data The company announced data from an ongoing Phase 1b study of investigational ME-401 in patients with indolent B-cell malignancies. It will present the data at the company's investor and analyst event, starting tomorrow at 8 a.m. ET. The company will also review progress across the pipeline of its four clinical-stage oncology candidates, with a focus on voruciclib, a cyclin-dependent kinase inhibitor with potent CDK9 inhibition. Show less Read more
Impact Snapshot
Event Time:
MEIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MEIP alerts
Opt-in for
MEIP alerts

from News Quantified
Opt-in for
MEIP alerts

from News Quantified